The Food and Drug Administration just approved Yescarta, a treatment that genetically modifies a patient's own white cells to battle lymphoma. The price? $373,000.
from Forbes Real Time https://www.forbes.com/sites/matthewherper/2017/10/18/fda-approves-another-amazing-and-costly-cancer-killing-gene-therapy/
via IFTTT
No comments:
Post a Comment